Ascension Saint Thomas concludes an extensive national search with the selection of Shubhada Jagasia, MD, MMHC, as President and CEO of Ascension Saint Thomas Hospital, Midtown and West campuses.
Offering nearly 30 years of clinical and health care administration experience, Dr. Jagasia most recently served as Chief of Staff for the Adult Hospital and Ambulatory Clinics at Vanderbilt University Medical Center. There, she successfully led the COVID service line as part of the pandemic response, created an innovative discharge and transitions program, and developed a patient and caregiver-centered end-of-life program. She also helped develop multiple new clinical programs, including a specialized service line catering to patients with high health care resources utilization. Her prior roles include Medical Director of the Eskind Diabetes Clinic and Vice-Chair of Clinical Affairs for the Department of Medicine at Vanderbilt.
Dr. Jagasia moved to Tennessee in 1994 to complete a postdoctoral fellowship at St. Jude Children’s Research Hospital in Memphis after graduating from King Edward Memorial Medical College in Mumbai, India. She then relocated to Nashville for her Internal Medicine residency, which she completed on the Ascension Saint Thomas Hospital Midtown and West campuses through the University of Tennessee Health Science Center. Dr. Jagasia continued her clinical training at Vanderbilt with a fellowship in Diabetes, Endocrinology and Metabolism. She also obtained a Masters of Management in Health Care from the Owen Graduate School of Management.
Dr. Jagasia joins Ascension Saint Thomas amid major expansion of the Heart, Transplant, Neuroscience and Critical Care programs on the West campus and a $300-million modernization of the Midtown campus. The widely anticipated Midtown development encompasses a new, state-of-the-art surgery and critical care tower, a new entrance and program enhancements for the Hospital for Women, a new Medical Office Building, a new Spine Institute with specialized surgical suites, a new specialty hospital for inpatient rehabilitation, and expansions to the Cancer Center.
“Dr. Jagasia will be a tremendous asset to our Ministry as we continue to drive innovation within healthcare,” said Tim Adams, President and CEO, Ascension Saint Thomas. “Dr. Jagasia will lead and enhance our already strong associate and clinician engagement across service lines within both facilities while providing Middle Tennesseans with world-class care. Additionally, she plans to continue her endocrinology work as a part of our medical staff.”
Dr. Jagasia succeeds Fahad Tahir, outgoing President and CEO of the Ascension Saint Thomas Hospital Midtown and West campuses, as he assumes the role of system Chief Strategy Officer for Ascension Saint Thomas. In partnership with Dr. Jagasia, and as part of his scope within the Chief Strategy Officer role, Fahad will lead service lines across the system, continue to support clinical program development, and maintain close engagement with physicians, hospital leadership and co-management boards. He will also remain a Co-Executive Sponsor of the Midtown modernization, clinical program development, and capital campaign, in partnership with the Ascension Saint Thomas Foundation.
Dr. Jagasia’s new role is effective on May 1, 2021.
